Medtronic (MDT)
93.03
-1.27 (-1.35%)
Medtronic is a global leader in medical technology, focused on developing and providing innovative therapeutic solutions to improve the lives of patients
The company specializes in a wide range of medical devices and therapies, addressing conditions in areas such as diabetes care, cardiovascular health, surgical innovations, and neurological disorders. Medtronic is committed to advancing healthcare through cutting-edge research, collaboration with healthcare providers, and a strong emphasis on patient-centered care, aiming to enhance the quality of life for millions around the world.

Via Benzinga · March 4, 2025

MEDTRONIC PLC (NYSEMDT) Reveals Intriguing Technical Aspects. Indications Suggest NYSE:MDT Could Be on the Verge of a Breakout. Here's What You Need to Know.
Via Chartmill · February 27, 2025

In a welcome move, Medtronic stock saw its Relative Strength Rating improve to 73 on Tuesday, up form 67 a day earlier.
Via Investor's Business Daily · February 25, 2025

Via The Motley Fool · February 24, 2025

The FDA approved Medtronic's BrainSense Adaptive DBS and Electrode Identifier for Parkinson's, enhancing therapy personalization and clinic efficiency.
Via Benzinga · February 24, 2025

The medical device maker has been a huge winner for its long-term shareholders.
Via The Motley Fool · February 21, 2025

The company reported fiscal third-quarter earnings and, on at least one metric, disappointed investors.
Via Investor's Business Daily · February 18, 2025

Stocks were volatile this week as bad news gave investors a reason to sell; that volatility will continue next week with key retail earnings and inflation news
Via MarketBeat · February 22, 2025

Medtronic is on track to complete a market reversal later this year as investments in technology and innovation begin to pay off.
Via MarketBeat · February 21, 2025

Via The Motley Fool · February 20, 2025

The company said its medical-surgical segment struggled with ongoing stapling market pressures and temporary shifts in U.S. distributor buying patterns.
Via Stocktwits · February 18, 2025

MDT earnings call for the period ending December 31, 2024.
Via The Motley Fool · February 18, 2025

Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session.
Via Chartmill · February 18, 2025

Stay updated with the movements of the S&P500 index in the middle of the day on Tuesday. Discover which stocks are leading as top gainers and losers in today's session.
Via Chartmill · February 18, 2025

Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Tuesday. Discover the gap up and gap down stocks in the S&P500 index.
Via Chartmill · February 18, 2025

Major U.S. indices are little-changed in Tuesday's midday trading as investors monitor recent geopolitical developments and anticipate the release of the latest FOMC minutes on Wednesday.
Via Benzinga · February 18, 2025

Medtronic reported Q3 revenue of $8.29 billion, missing estimates, while EPS of $1.39 topped forecasts. The company reaffirmed its FY25 organic growth guidance.
Via Benzinga · February 18, 2025

U.S. stock futures rose on Tuesday following a mixed close on Friday after the Presidents' Day holiday on Monday.
Via Benzinga · February 18, 2025

Via Benzinga · February 18, 2025

Via Benzinga · February 18, 2025

DexCom reported Q4 revenue of $1.11 billion, surpassing estimates. The company reaffirmed its 2025 outlook while analysts highlighted long-term growth potential.
Via Benzinga · February 14, 2025